Recall: Dabigatran

Apr. 2023Pharmacy Updates
Ascend Laboratories LLC has recalled 10 lots of Dabigatran capsules due to the presence of a nitrosamine, N-nitroso-dabigatran, above the established Acceptable Daily Intake (ADI) level. Dabigatran is a drug used as an oral anticoagulant to lower the risk of stroke and blood clots. Read more about the Dabigatran recall.

Recent Announcements

Training Webinar: Conversio Health COPD Management Program

Please join us for a live training webinar by UPMC Health Plan that will provide an overview of a comprehensive COPD management program from Conversio Health.
Jan. 2026Education/Webinars

Provider Directory Updates and Required Attestation

As you know, UPMC Health Plan requires all providers to verify their provider directory information at least every 90 days (quarterly).
Jan. 2026Important Notices

UPMC Dental Advantage celebrates 15-years of growth

From pilot program to now serving all product lines
Jan. 2026What's New